Embla Medical hf. OSSFF

Set alert

Price alert · OSSFF

All alert types
4.53 USD 0.00 0.00%

At close · Oct 30

5.11 Day range 5.11
4.15 52-week range 5.33
YTD
-14.94%
1 year
-5.73%
Open
5.11
Prev close
4.53
Mkt cap
1.92B
Vol
40
Avg vol
6
EPS
0.22
P/E
20.57
More statistics
Low
5.11
High
5.11
Earnings
Oct 20, 2026

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for OSSFF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.24 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 3
  • P/B 3

Valuation

P/E 26.6×
FY 2016: 48.3×FY 2017: 44.6×FY 2018: 30.5×FY 2019: 47.8×FY 2020: 503×FY 2021: 40.3×FY 2022: 46.3×FY 2023: 30.1×FY 2024: 29.8×FY 2025: 26.6×
FY 2016 5y median 30.1× FY 2025
P/S 2.4×
FY 2016: 4.9×FY 2017: 4.4×FY 2018: 4.0×FY 2019: 4.7×FY 2020: 5.3×FY 2021: 3.6×FY 2022: 2.7×FY 2023: 2.3×FY 2024: 2.4×FY 2025: 2.4×
FY 2016 5y median 2.4× FY 2025
P/B 2.6×
FY 2016: 5.5×FY 2017: 5.0×FY 2018: 4.6×FY 2019: 5.7×FY 2020: 5.9×FY 2021: 4.1×FY 2022: 3.0×FY 2023: 2.5×FY 2024: 2.6×FY 2025: 2.6×
FY 2016 5y median 2.6× FY 2025
P/FCF 19.1×
FY 2016: 61.1×FY 2017: 45.6×FY 2018: 64.0×FY 2019: 51.1×FY 2020: 49.1×FY 2021: 34.6×FY 2022: 55.5×FY 2023: 34.0×FY 2024: 26.5×FY 2025: 19.1×
FY 2016 5y median 34.0× FY 2025
EV/EBITDA 14.3×
FY 2016: 28.7×FY 2017: 26.3×FY 2018: 22.3×FY 2019: 24.6×FY 2020: 42.9×FY 2021: 19.9×FY 2022: 20.0×FY 2023: 14.8×FY 2024: 14.4×FY 2025: 14.3×
FY 2016 5y median 14.8× FY 2025
EV/Sales 2.8×
FY 2016: 5.1×FY 2017: 4.6×FY 2018: 4.3×FY 2019: 5.2×FY 2020: 5.9×FY 2021: 4.1×FY 2022: 3.3×FY 2023: 2.8×FY 2024: 2.9×FY 2025: 2.8×
FY 2016 5y median 2.9× FY 2025
FCF Yield 5.2%
FY 2016: 1.6%FY 2017: 2.2%FY 2018: 1.6%FY 2019: 2.0%FY 2020: 2.0%FY 2021: 2.9%FY 2022: 1.8%FY 2023: 2.9%FY 2024: 3.8%FY 2025: 5.2%
FY 2016 5y median 2.9% FY 2025

Profitability

Gross Margin 58.2%
FY 2016: 63.1%FY 2017: 62.4%FY 2018: 63.1%FY 2019: 63.9%FY 2020: 62.1%FY 2021: 63.4%FY 2022: 61.2%FY 2023: 61.8%FY 2024: 62.5%FY 2025: 58.2%
FY 2016 5y median 61.8% FY 2025
Operating Margin 13.4%
FY 2016: 13.9%FY 2017: 13.2%FY 2018: 12.9%FY 2019: 14.4%FY 2020: 3.5%FY 2021: 13.5%FY 2022: 9.0%FY 2023: 11.4%FY 2024: 13.2%FY 2025: 13.4%
FY 2016 5y median 13.2% FY 2025
Net Margin 9.0%
FY 2016: 9.8%FY 2017: 10.1%FY 2018: 13.0%FY 2019: 9.6%FY 2020: 1.0%FY 2021: 8.9%FY 2022: 5.9%FY 2023: 7.4%FY 2024: 8.0%FY 2025: 9.0%
FY 2016 5y median 8.0% FY 2025
ROE 9.7%
FY 2016: 10.9%FY 2017: 11.5%FY 2018: 14.9%FY 2019: 11.7%FY 2020: 1.1%FY 2021: 10.3%FY 2022: 6.7%FY 2023: 8.3%FY 2024: 8.8%FY 2025: 9.7%
FY 2016 5y median 8.8% FY 2025
ROIC 6.6%
FY 2016: 8.2%FY 2017: 9.1%FY 2018: 8.0%FY 2019: 7.7%FY 2020: 1.3%FY 2021: 6.5%FY 2022: 4.2%FY 2023: 5.6%FY 2024: 6.2%FY 2025: 6.6%
FY 2016 5y median 6.2% FY 2025
ROA 5.0%
FY 2016: 6.8%FY 2017: 7.3%FY 2018: 8.7%FY 2019: 6.1%FY 2020: 0.5%FY 2021: 5.1%FY 2022: 3.2%FY 2023: 4.2%FY 2024: 4.4%FY 2025: 5.0%
FY 2016 5y median 4.4% FY 2025

Growth (YoY)

Revenue 12.7%
FY 2016: 7.8%FY 2017: 9.2%FY 2018: 7.8%FY 2019: 12.0%FY 2020: -8.3%FY 2021: 14.2%FY 2022: -0.0%FY 2023: 9.3%FY 2024: 8.8%FY 2025: 12.7%
FY 2016 FY 2025
Operating Income 14.7%
FY 2016: -6.7%FY 2017: 3.7%FY 2018: 5.5%FY 2019: 24.9%FY 2020: -77.4%FY 2021: 335.8%FY 2022: -33.4%FY 2023: 37.8%FY 2024: 26.1%FY 2025: 14.7%
FY 2016 FY 2025
EPS (diluted) 25.0%
FY 2016: 0.0%FY 2017: 8.3%FY 2018: 46.2%FY 2019: -15.8%FY 2020: -90.1%FY 2021: 849.4%FY 2022: -33.3%FY 2023: 40.0%FY 2024: 14.3%FY 2025: 25.0%
FY 2016 FY 2025
Free Cash Flow 54.8%
FY 2016: 0.2%FY 2017: 31.2%FY 2018: -29.5%FY 2019: 64.4%FY 2020: 7.6%FY 2021: 8.2%FY 2022: -52.8%FY 2023: 49.4%FY 2024: 47.6%FY 2025: 54.8%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 1.8×FY 2017: 1.8×FY 2018: 2.3×FY 2019: 2.2×FY 2020: 2.2×FY 2021: 1.7×FY 2022: 1.5×FY 2023: 1.9×FY 2024: 1.9×FY 2025: 1.5×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 0.9×
FY 2016: 1.2×FY 2017: 1.2×FY 2018: 1.5×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 0.9×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.6×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.6×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.3×
FY 2016: 1.3×FY 2017: 1.2×FY 2018: 1.5×FY 2019: 2.1×FY 2020: 4.4×FY 2021: 2.5×FY 2022: 3.5×FY 2023: 2.7×FY 2024: 2.4×FY 2025: 2.3×
FY 2016 5y median 2.5× FY 2025
Interest Coverage 5.9×
FY 2016: 19.9×FY 2017: 23.4×FY 2018: 16.6×FY 2019: 9.7×FY 2020: 2.3×FY 2021: 7.9×FY 2022: 4.9×FY 2023: 4.2×FY 2024: 4.8×FY 2025: 5.9×
FY 2016 5y median 4.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.3%FY 2017: 0.3%FY 2018: 0.4%FY 2019: 0.3%FY 2020: 0.3%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 15.3%FY 2017: 12.7%FY 2018: 11.5%FY 2019: 13.7%FY 2020: 160.5%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31